0
0.5
1
1.5
2+
Severe case or mortality
46%
Improvement
Relative Risk
Paxlovid Najjar-Debbiny et al. EARLY TREATMENT
Is early treatment with paxlovid beneficial for COVID-19?
Retrospective 180,351 patients in Israel (January - February 2022)
Lower severe cases with paxlovid (p=0.00024)
c19early.org
Najjar-Debbiny et al., Clinical Infect.., Jun 2022
Favors paxlovid
Favors control